Media Center

Learn More

Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 Years and Older

Johnson & Johnson announces significant progress towards its climate goals—100% renewable electricity for all sites in the United States, Canada and Europe by 2023

Johnson & Johnson Enters into Agreement to Provide its Single-Shot COVID-19 Vaccine for the World’s Most Vulnerable People through Novel Humanitarian Buffer

U.S. CDC Advisory Committee Unanimously Recommends Johnson & Johnson COVID-19 Vaccine as a Booster for All Eligible Individuals Who Receive Authorized COVID-19 Vaccines

Latest Press Releases

Innovation

December 12, 2021

New Data from CARTITUDE-1 Study Show Continued Deep and Durable Responses of Ciltacabtagene Autoleucel (cilta-cel) in Treatment of Heavily Pretreated Patients with Multiple Myeloma

Innovation

December 12, 2021

DePuy Synthes’ VELYS Robotic-Assisted Solution Paves the Way For Next Generation Knee Replacement Surgery In Australia With The First Clinical Case At Mater Hospital In Sydney

Innovation

December 11, 2021

Janssen Presents Updated Results Evaluating First-in-Class Talquetamab (GPRC5DxCD3 Bispecific Antibody) in Heavily Pretreated Patients with Multiple Myeloma

Innovation

December 11, 2021

New Clinical and Real-World Data Support Use of DARZALEX^® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma

Innovation

December 11, 2021

New Data from Phase 3 GLOW Study Show Fixed-Duration Treatment with IMBRUVICA^®(ibrutinib) Plus Venetoclax Demonstrated Deeper and Sustained Undetectable Minimal Residual Disease Outcomes in First-Line Chronic Lymphocytic Leukemia

Financial

December 10, 2021

Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results

See All Press Releases

In the Media?

Sign up for Johnson & Johnson company news and press releases delivered right to your inbox.

Sign Up
Contact Media Relations

September 21, 2016

Thank you for your interest in learning more about our company. We care about your questions and concerns.

Contact Us

5 Ways We're Helping Build a World of Well

Learn more about how we're helping build a world of well through efforts in five key areas of healthcare.

J&J Fast Facts

Our Company

We Work All Over the World

We have over 134,000 employees working across more than 260 operating companies located in 60 countries around the world.

Get to know Johnson & Johnson

See All Fast Facts

Social Media

#RSV doesn't only impact children. The @NFIDvaccines reports over 177,000 annual hospitalizations for adults aged 6… https://t.co/umufcYjy1b

JNJNews
RT @ncl_tweets: We can't wait any longer to get vaccinated for #COVID19. Hear more from @sallygreenberg, Executive Director of the @ncl_twe…

JNJNews
#JNJ MedTech is committed to addressing disparities in healthcare. Hear more from Carla Calizaire, Global Leader, D… https://t.co/Vl0xQP65CO

JNJNews

More From Johnson & Johnson

ON NOW

Health & Wellness

4 Things to Know About RSV in the Time of COVID-19

Respiratory syncytial virus (RSV) is normally rampant in winter—but the pandemic has changed the behavior of this common and potentially dangerous infection. Here's how to protect your family this season, and learn how Johnson & Johnson is working to keep us all safer from RSV.

ON NOW

Woman shows dapivirine ring to three young women

Innovation

This Ring May Just Help Protect Women Against HIV

For World AIDS Day, learn how a new tool will help give this group greater power to prevent HIV on a monthly basis.

ON NOW

Four pictures show a scientist; a mother and child; businesspeople shaking hands; a woman outside; and wind turbines

Internet Explorer is no longer supported by this website.

Media Center

Latest Press Releases

J&J Fast Facts

Social Media

More From Johnson & Johnson